Twinpig Biolab
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $2.4M
Investors
- 5
About Twinpig Biolab
Twinpig Biolab, Inc.Founded in 2019 and headquartered in Seoul, South Korea, Twinpig Biolab, Inc. focuses on the development of biopharmaceutical solutions.Twinpig Biolab, Inc. specializes in advanced biopharmaceutical solutions focused on tumor microenvironment (TME) editing and innovative drug delivery systems. Its core offerings include targeted therapies aimed at removing tumor-promoting cells and regulating the activity of specific TME constituents such as tumor-associated macrophages (TAM), cancer-associated fibroblasts (CAF), and myeloid-derived suppressor cells (MDSC). The company's proprietary technology utilizes nanoparticle drug delivery systems that encapsulate various therapeutic agents, including mRNA, siRNA, peptides, and small molecules.Twinpig Biolab generates revenue through strategic partnerships and collaborations with research institutions and pharmaceutical companies for the development and commercialization of its innovative therapies. Its revenue model is based on B2B transactions, supplying proprietary drug delivery systems and TME-targeting therapies to its partners, structured around milestone payments and royalty agreements that depend on successful clinical outcomes. The company will utilize these funds primarily for research and development initiatives and to advance its pharmaceuticals to meet international standards. Twinpig Biolab is also focused on expanding into new markets and geographic regions, particularly targeting North America and Europe, with potential product launches slated for 2026.
Who invested in Twinpig Biolab
5 investors across 1 round
See all investors in Twinpig Biolab
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 27, 2023
Amount
$2.4M
Investors
Questions about Twinpig Biolab
Who invested in Twinpig Biolab?
Twinpig Biolab has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Twinpig Biolab raised?
Twinpig Biolab has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Twinpig Biolab last raise money?
Twinpig Biolab's most recent round on record is a Series A, in Dec 2023.
What does Twinpig Biolab do?
Twinpig Biolab is a biotechnology company.
Where is Twinpig Biolab headquartered?
Twinpig Biolab is headquartered in Seoul, South Korea.
Which VCs invest in companies like Twinpig Biolab?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Twinpig Biolab's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Twinpig Biolab? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.